(Q39180901)

English

Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation

scientific article published on August 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

author name string

Ruizan Shi

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Hongwei Peng

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Xiangfei Yuan

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Xiuli Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yanjun Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dongmei Fan

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Xuyi Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dongsheng Xiong

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Journal of Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

114

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1890-1900

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Life-or-death decisions by the Bcl-2 protein family.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

The Bcl2 family: regulators of the cellular life-or-death switch

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Cell death: critical control points

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Control of apoptosis by p53.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Multi-functional nanocarriers to overcome tumor drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Drug Development for Cancer Chemoprevention: Focus on Molecular Targets

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Induction of apoptosis in K562/ADM cells by gamma-linolenic acid involves lipid peroxidation and activation of caspase-3.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Inhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Advances in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Three decades of P-gp inhibitors: skimming through several generations and scaffolds.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

The P-glycoprotein multidrug transporter.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Role of transcription factor activator protein 1 (AP1) in epidermal growth factor-mediated protection against apoptosis induced by a DNA-damaging agent

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Protooncogenes as mediators of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Overcoming resistance to fulvestrant (ICI182,780) by downregulating the c-ABL proto-oncogene in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCB.24533

21 January 2018

Identifiers

10.1002/JCB.24533

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39180901&oldid=1811924796"